Publication | Closed Access

13LBA Improved overall survival by adding regional hyperthermia to neo-adjuvant chemotherapy in patients with localized high-risk soft tissue sarcoma (HR-STS): Long-term outcomes of the EORTC 62961/ESHO randomized phase III study

Surgical OncologyRegional HyperthermiaMedicineCancer ManagementNeo-adjuvant ChemotherapyCancer TreatmentOncologyRadiation OncologyEortc 62961/Esho